Whenever a pharmaceutical company signs an in-licensing contract, the quality of the existing data in the form of files or dossiers should be duly evaluated. DADA is not only well able to evaluate this regulatory dossier, but we can also support you in assessing the proposed contracts concerning this transaction. And via our network we can bring an interesting project to the attention of potential in-licensors.